Rating History for Pandion Therapeutics (PAND) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/25/2021 | Vikram Purohit | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
25.63 (60.05) |
134.3% | Details |
 |
|||||||
